Naloxone Hydrochloride Injection
Product Images NDC 51662-1529

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 51662-1529). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51662 1529 2 Pouch Labeling

Label for NALOXONE HYDROCHLORIDE INJECTION, USP 2 mg/2 mL (1 mg/mL) 2 mL syringe. Includes dosage form as injection with intramuscular, intravenous, and subcutaneous routes. Displays NDC 51662-1529-2, lot number, and expiration date. Labeler is HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA. Additional usage and storage instructions are partially visible.*

FDA Label Image

51662 1529 3 Box Labeling

Label for Naloxone Hydrochloride Injection USP 2 mg/2 mL (1 mg/mL) 2 mL syringe, box of 10, manufactured by HF Acquisition Co LLC DBA HealthFirst. The label includes NDC 51662-1529-3, lot number, expiry date, and usage instructions for intramuscular, intravenous, or subcutaneous administration.*

FDA Label Image

51662 1529 3 Serialized Rfid Labeling

NALOXONE HYDROCHLORIDE injection label from HF Acquisition Co LLC, DBA HealthFirst. The small white label includes barcode and textual information, referencing the product's package insert and distribution details. Specific NDC codes and identifiers are visible on the label.*

FDA Label Image

1 (I 1)

An instructional illustration showing a person removing a cap from the syringe tip of a prefilled syringe. The image highlights the syringe tip and cap, demonstrating preparation of the syringe prior to injection.*

FDA Label Image

2 (I 2)

An instructional illustration showing hands preparing an injection. The left panel depicts a hand opening a sealed package containing a needle and syringe. The right panel shows another hand holding the syringe, indicating the process of assembly or preparation for injection.*

FDA Label Image

3 (I 3)

An instructional line drawing showing the removal of a needle cap from a syringe. The illustration depicts a hand holding a syringe with the other hand pulling the needle cap upward, guided by arrows indicating the motion to remove the cap.*

FDA Label Image

4 (I 4)

An instructional illustration showing hands preparing a syringe for injection. One hand holds the syringe with a needle exposed, and the other hand is pulling the plunger to draw fluid into the syringe. A droplet is shown at the tip of the needle, indicating fluid is present.*

FDA Label Image

5 (I 5)

Instructional illustration showing three methods for activating a device using finger activation, thumb activation, or surface activation. Each method depicts a hand manipulating the device to engage or deploy the mechanism, indicated by an arrow and labeled accordingly.*

FDA Label Image

Serialized Label (Serialized Label)

NDC barcode label for NALOXONE HYDROCHLORIDE injection distributed by HF Acquisition Co., LLC, Mukilteo, WA. The label includes product identifiers such as barcode (01) 00351662152911, date code (17) 220228, batch number (21) 140465551569, and a alphanumeric code (10) ABC123, along with the instruction to see the manufacturer's package insert. Marked RX ONLY.*

FDA Label Image

Box Labeling (Single Dose Syringe Packaging)

The packaging label for Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL), single-dose disposable prefilled syringe. The label indicates routes of administration as intravenous, intramuscular, or subcutaneous. It includes assembly instructions for syringe use and states it is Rx only. The labeler is Dr. Reddy's Laboratories Inc., Princeton, NJ, with product made in India.*

FDA Label Image

Structure (Structure)

Chemical structure of naloxone hydrochloride, showing its molecular arrangement with hydroxyl, carbonyl, and amine groups, including two water molecules indicated as hydration.*

FDA Label Image

Syringe (Syringe Labeling)

Label for Naloxone Hydrochloride Injection, USP 2 mg/2 mL (1 mg/mL) single-dose. The label includes dosage markings up to 1.5 mL, barcode, and distributor information for Dr. Reddy's Laboratories Inc. It specifies prescription use only and instructs to see the insert for single dose usage directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.